• Privacy policy
  • T&C’s
  • About Us
    • FAQ
    • Meet the Team
  • Contact us
TLE ONLINE SHOP!
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
  • JOBS
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
  • JOBS
No Result
View All Result
The London Economic
No Result
View All Result
Home Lifestyle Health

All-in-one polypill to treat blood pressure & cholesterol levels slashes risk of heart attack or stroke, study

Researchers found that a single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of heart disease

Steve Beech by Steve Beech
2019-09-18 22:00
in Health, Lifestyle
FacebookTwitterLinkedinEmailWhatsapp

A new all-in-one ‘polypill’ to treat blood pressure and cholesterol levels slashes the risk of a heart attack or stroke by 25 per cent, according to a new study.

Researchers found that a single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of heart disease by a quarter.

“Polypills” for prevention of cardiovascular disease have previously been studied in low- and middle-income countries where other health care barriers exist, according to the research team.

But the new American study, published in the New England Journal of Medicine (NEJM), involved mostly low income, primarily black adults from a community health centre in Mobile, Alabama.

Study senior author Professor Thomas Wang, said: “The pill may address some of the barriers that contribute to disparities in health based on geography, socio-economic class and other parameters that we know have existed in this country and other countries for a while now.”

Prof Wang, chief of the Division of Cardiovascular Medicine at Vanderbilt University Medical Centre (VUMC), added: “Despite advances in the prevention and treatment of cardiovascular disease, it remains the No.1 global killer of both men and women.”

The trial of people without cardiovascular disease enrolled 303 adults – 96 per cent of them black, 60 per cent female and 75 per cent on low incomes.

RelatedPosts

The cost-of-living crisis is driving workers to hybrid working, what’s the future of office wear?

Inflation hits double figures and reaches new 40-year high

Wages fall at fastest rate on record

Lucky Numbers and Horoscopes for today 17 August 2022

Half were assigned to take a daily polypill for 12 months and the other half assigned to continue their usual routine medical care.

The participants underwent a standard medical exam, blood pressure measurement, and blood cholesterol testing during their initial visit, a two-month visit, and a 12-month visit.

At the end of the year, study participants who had taken the polypill had decreased blood pressure by an average of 7 mm Hg and reduced LDL – or “bad” – cholesterol levels as compared with participants in the usual care group.

This translated to an estimated 25 per cent reduction in the risk of experiencing a cardiovascular event.

Study lead author Dr Daniel Muñoz, a cardiologist at VUMC, said: Patients seeking care at community health centres have traditionally been under-represented in clinical trials.

“We need to better understand what works and what doesn’t in these settings so we can improve outcomes for our fellow citizens who may be the most vulnerable.”

He addd: “We think there are advantages to combining population-based strategies like the polypill with all of the virtues of precision medicine.

“It is a running start for people who need access to some medical care, but precision medicine should still be used to add therapy and adjust therapy.”

Simple blood test could warn young people they are likely to develop cancer or heart disease… decades in advance

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

Trending on TLE

  • All
  • trending
Abdollah

‘Rescue us’: Afghan teacher begs UK to help him escape Taliban

CHOMSKY: “If Corbyn had been elected, Britain would be pursuing a much more sane course”

What If We Got Rid Of Prisons?

More from TLE

How To Make: Easy Homemade Wraps

Nine-in-ten Londoners struggling to pay rent amid cost of living crunch

University students forced to waste £1bn on empty accommodation

Mum thanks strangers who donated to terminally-ill daughter after revealing family couldn’t heat home due to cost of living crisis

Trump Watch: There is no alt-right, just Nazis

Scrap the Nominal Fee

The Wolfpack : Film Review

Brighton player completes loan switch to Fulham

Homes of 153m people at risk as seas may rise up to 8ft this century: interactive map

Express confuses Raducanu for Fernandez in article defending Leave voters

JOBS

FIND MORE JOBS

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.




No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Meet the Team
    • Privacy policy
  • Contact us

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.